These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34728983)

  • 41. Bacterial Infections Confer a Risk of Progression to Acute-on-Chronic Liver Failure in Patients with HBV-Related Compensated Cirrhosis During Severe Hepatitis Flares.
    Chu J; Yang Y; Liu Y; Pei L; Zhou Y; Lu T; Zhang Y; Hu H; Li Y; Yang F; Lin S
    Infect Dis Ther; 2022 Oct; 11(5):1839-1851. PubMed ID: 36151452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis.
    Mehta G; Rousell S; Burgess G; Morris M; Wright G; McPherson S; Frenette C; Cave M; Hagerty DT; Spada A; Jalan R
    J Clin Exp Hepatol; 2018 Sep; 8(3):224-234. PubMed ID: 30302038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single center validation of mortality scores in patients with acute decompensation of cirrhosis with and without acute-on-chronic liver failure.
    Alexopoulou A; Vasilieva L; Mani I; Agiasotelli D; Pantelidaki H; Dourakis SP
    Scand J Gastroenterol; 2017 Dec; 52(12):1385-1390. PubMed ID: 28851246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure.
    Kerbert AJC; Gupta S; Alabsawy E; Dobler I; Lønsmann I; Hall A; Nielsen SH; Nielsen MJ; Gronbaek H; Amoros À; Yeung D; Macnaughtan J; Mookerjee RP; Macdonald S; Andreola F; Moreau R; Arroyo V; Angeli P; Leeming DJ; Treem W; Karsdal MA; Jalan R
    JHEP Rep; 2021 Dec; 3(6):100355. PubMed ID: 34805815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between effective hepatic blood flow and the severity and prognosis of hepatitis B virus-related acute on chronic liver failure.
    Chen D; Wen S; Wu Z; Gu Y; Chen Y; Chen X; Zhang Y; Lin B; Peng L; Zheng Y; Gao Z
    Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):246-254. PubMed ID: 32282547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Severity and Outcome of Acute-on-Chronic Liver Failure is Dependent on the Etiology of Acute Hepatic Insults: Analysis of 368 Patients.
    Shalimar ; Kedia S; Mahapatra SJ; Nayak B; Gunjan D; Thakur B; Acharya SK
    J Clin Gastroenterol; 2017 Sep; 51(8):734-741. PubMed ID: 28296656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphocyte-To-Monocyte Ratio as the Best Simple Predictor of Bacterial Infection in Patients with Liver Cirrhosis.
    Piotrowski D; Sączewska-Piotrowska A; Jaroszewicz J; Boroń-Kaczmarska A
    Int J Environ Res Public Health; 2020 Mar; 17(5):. PubMed ID: 32155772
    [No Abstract]   [Full Text] [Related]  

  • 48. Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF).
    Mezzano G; Cárdenas A; Aguilar F; Pavesi M; Solé C; Napoleone L; Graupera I; Juanola A; Carol M; Pose E; Fabrellas N; Hernaez R; Martínez J; Saliba F; Arroyo V; Sola E; Gines P
    Dig Liver Dis; 2021 Jun; 53(6):738-745. PubMed ID: 33446445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic factors in acute-on-chronic liver failure: a prospective study from western India.
    Khot AA; Somani P; Rathi P; Amarapurkar A
    Indian J Gastroenterol; 2014 Mar; 33(2):119-24. PubMed ID: 24122317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis.
    Laschtowitz A; Zachou K; Lygoura V; Pape S; Derben F; Jaeckel E; Oller-Moreno S; Weidemann S; Krech T; Piecha F; Schön G; Liebhoff AM; Al Tarrah M; Heneghan M; Drenth JPH; Dalekos G; Taubert R; Lohse AW; Schramm C
    JHEP Rep; 2021 Aug; 3(4):100321. PubMed ID: 34381983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.
    Moreau R; Jalan R; Gines P; Pavesi M; Angeli P; Cordoba J; Durand F; Gustot T; Saliba F; Domenicali M; Gerbes A; Wendon J; Alessandria C; Laleman W; Zeuzem S; Trebicka J; Bernardi M; Arroyo V;
    Gastroenterology; 2013 Jun; 144(7):1426-37, 1437.e1-9. PubMed ID: 23474284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of clinical outcomes and impact of SVR in American and Chinese patients with chronic hepatitis C.
    Rao H; Liu H; Wu E; Yang M; Feng B; Lin A; Fei R; Fontana RJ; Wei L; Lok AS
    JHEP Rep; 2020 Aug; 2(4):100136. PubMed ID: 32715286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Model for end-stage liver disease combined with arterial blood lactate to assess the prognosis of hepatitis B virus-associated acute-on-chronic liver failure: a retrospective analysis of 97 cases].
    Yao YH; Zhao WF; Gan JH
    Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):256-260. PubMed ID: 31082335
    [No Abstract]   [Full Text] [Related]  

  • 54. Pro-adrenomedullin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
    Yan H; Jin S; Liang L; Du J; Aithal GP; Li L
    Scand J Gastroenterol; 2020 May; 55(5):606-614. PubMed ID: 32476510
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.
    Krassenburg LAP; Maan R; Ramji A; Manns MP; Cornberg M; Wedemeyer H; de Knegt RJ; Hansen BE; Janssen HLA; de Man RA; Feld JJ; van der Meer AJ
    J Hepatol; 2021 May; 74(5):1053-1063. PubMed ID: 33242501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thromboelastography maximum amplitude predicts short-term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure.
    Zhu Z; Yu Y; Ke Y; Deng D; Zheng G; Hua X; Gao G
    Exp Ther Med; 2020 Sep; 20(3):2657-2664. PubMed ID: 32765759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Impact of Metabolic Syndrome on the Prognosis of High-Risk Alcoholic Hepatitis Patients: Redefining Alcoholic Hepatitis.
    Habib S; Murakami T; Takyar V; Patel K; Dominguez C; Zhan Y; Mehrpour O; Hsu CH
    Gastroenterology Res; 2023 Feb; 16(1):25-36. PubMed ID: 36895697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis.
    Kaur S; Hussain S; Kolhe K; Kumar G; Tripathi DM; Tomar A; Kale P; Narayanan A; Bihari C; Bajpai M; Maiwall R; Gupta E; Sarin SK
    JHEP Rep; 2021 Aug; 3(4):100303. PubMed ID: 33997748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score.
    Chang J; Höfer P; Böhling N; Lingohr P; Manekeller S; Kalff JC; Dohmen J; Kaczmarek DJ; Jansen C; Meyer C; Strassburg CP; Trebicka J; Praktiknjo M
    JHEP Rep; 2022 Mar; 4(3):100442. PubMed ID: 35198929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure.
    Li J; Liang X; You S; Feng T; Zhou X; Zhu B; Luo J; Xin J; Jiang J; Shi D; Lu Y; Ren K; Wu T; Yang L; Li J; Li T; Cai Q; Sun S; Guo B; Zhou X; Chen J; He L; Li P; Yang H; Hu W; An Z; Jin X; Tian J; Wang B; Chen X; Xin S; Li J;
    J Hepatol; 2021 Nov; 75(5):1104-1115. PubMed ID: 34090929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.